According to epidemiological studies, at least one third of NASH patients would progress to cirrhosis and HCC1,3–5,41, that is why we investigated MPP9 mRNA expression level in the four group of patients from the learning datasets (GSE48452 and GSE61260). Here, MPHOSPH9 is linked to metabolic dysfunction-associated steatohepatitis.